Moreover,it has been shown that PPARγ1/2 activation suppressed the high level ofendogenous COX-2 in normalprostate epithelial cells [83] while TZDs mediatedapoptosis in prostate cancer cells through inhibition of Bcl-xL/Bcl-2 functions[84]. The gene discussed is PPARG; the disease is prostate carcinoma.